Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-03

Clinical Trial Update: Pivotal Study of the Intravenous Blood Glucose (IVBG) System, In-Clinic Setting

View source ↗

Summary

DexCom reports completion of a pivotal in-clinic study evaluating the Intravenous Blood Glucose (IVBG) System for diabetes management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous Blood Glucose (IVBG) System

Snippet

Sponsor: DexCom, Inc. | Conditions: Diabetes, Hyperglycemia | Status: COMPLETED